In 2026, the Beijing Financial Court and the High People's Court of Beijing Municipality("Beijing High People's Court")ruled that Chinese mainland courts had jurisdiction over securities fraud involving a Cayman Islands company listed on the Hong Kong Stock Exchange (HKEX). This landmark decision sets a precedent as the first instance in which judicial authorities in Chinese mainland applied the Securities Law of the PRC (the "Securities Law") extraterritorially. The decision is recognized as a "typical case" and has been included in theReport on the Work of the Supreme People's Court (2026)[1]...
Han Kun Law Offices
Offices
Overview
Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions and compliance matters.
Our main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, asset management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/competition, data protection, private client/wealth management, intellectual property, bankruptcy and restructuring and dispute resolution.
We have more than 900 professionals located in Beijing, Shanghai, Shenzhen, Hangzhou, Wuhan, Haikou, Hong Kong, Singapore, New York, Silicon Valley and London.
All our lawyers are graduates of top universities and have extensive experience in complex cross-border transactions and dispute resolution as counsel to both Chinese and foreign clients.
Our working languages include Chinese, English, Japanese, Korean and German.
Year this Office was Established: 2004
Lawyers Worldwide: 900
Areas of Practice
Professionals
Partners
Yijun Chao
Partner
Xianglin Chen
Partner
Dafei Chen
Partner
Rong (Estella) Chen
Partner
Yang Chen
Partner
Xiaoming Deng
Partners
Min Duan
Partner
Zhichao(Kevin) Duan
Partner
Rong Fang
Partner
Chuan Min (Jerald) Foo
Partner
Lin Gui
Partner
Yang Han
Partner
Chunyan He
Partner
Jun He
Partner
Rui Huang
Partner
Rong (Reese) Huang
Partner
Dongni Jiang
Partners
Wenyu Jin
Partner
Tao Lan
Partner
Chuo Ming Leong
Partner
Xun Li
Partner
Jing Li
Partner
Jiajia(Loretta) Li
Partner
Zhuowei (Joyce) Li
Partner
SHENG LI
Partner
WEI (DAVID) LI
Partner
Xiaoming Li
Partner
Chaoying (Charles) Li
Partner
Shijia LI
Partner
Baofu Li
Partner
Ying Li
Partners
Yipu Li
Partners
Yixin Lin
Partner
Ruina Liu
Partner
Ruijie (Rae) Liu
Partner
Dong (Eric) Liu
Partner
Jiaxin LIU
Partner
Jing Liu
Partner
Long Liu
Partner
Xiayi Liu
Partner
Lifeng Lu
Partner
Zaiguang LU
Partner
Rui Luo
Partner
Shaolin Luo
Partner
Chen Ma
Partner
Xiu Pei
Partner
Lu Ran
Partner
Jing (Gilbert) Shen
Partners
Da Shi
Partners
Lei (Ray) Shi
Partner
Haining Song
Partner
Hua Tu
Partner
Xin (Gloria) Wang
Partner
Xikang Wang
Partner
Shu WANG
Partner
Jin Wang
Partner
Xiaowei WEI
Partner
Lili WU
Partner
Kaiying WU
Partner
Shipo (Angus) Xie
Partners
Ying (Gloria) Xu
Partner
Tiecheng YANG
Partner
Ying YANG
Partner
Yang You
Partner
Lan Yu
Partner
Shiye Yuan
Partner
Liming Yuan
Partner
Jian Zhang
Partner
Yaxing Zhang
Partner
Tao ZHANG
Partner
Zhao Zhang
Partner
Pei Zhao
Partner
Bin ZHI
Partner
Ying (Tracy) ZHOU
Partner
Lin ZHOU
Partner
Chengyao(Aaron) ZHOU
Partner
Jun ZHU
Partner
Qimin(Rebecca) Zhu
PartnerAssociates
Of Counsel
Han Chen
Counsel
Junfeng Cui
Of Counsel
Jie (Jessie) Dong
Of Counsel
Cencen (Miko) Feng
Of Counsel
Xiao Guo
Of Counsel
Zhehao Li
Of Counsel
Qian Li
Of Counsel
Jingbo Luo
Of Counsel
Bing San
Of Counsel
Yikai Wang
Of Counsel
Zhenyu Wang
Of Counsel
Yichen Wu
Of Counsel
Ying Zeng
Of Counsel
Qi Zhang
Of Counsel
Xinfeng Zhang
Of Counsel
Yuxuan Zhang
Of Counsel
Yunzhi Zhao
Of CounselOther
Xiaomeng Dong
Manager of trademark application department
Michael Jiawei He
Chief Marketing Officer
Chengrong (Paul) Li
Partner & Solicitor
Sara Shao
Business Development Manager
Tongyi Wang
Marketing
Jenny Xu
MarketingArticles
China's HGR Draft Rules Signal Regulatory Easing: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments)
On May 8, 2026, the National Health Commission ("NHC") released theImplementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments)("Draft for Comments"), proposing amendments to the currentImplementing Rules for the Administrative Regulation on Human Genetic Resources("Current Implementing Rules") formulated by the Ministry of Science and Technology ("MOST") in 2023 (for our interpretation of the Current Implementing Rules, please see our previous article:Han Kun Perspective First Release: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources), and is soliciting public comments...
Press releases
Han Kun Advises Everest Medicines in Acquiring an Exclusive License with Vcare PharmaTech for Sumecigrel, a P2Y12 receptor antagonist, in Asia-Pacific Markets
On June 9, 2026, Everest Medicines (HKEX: 1952) announced that it had entered into an agreement with Jiangsu Vcare PharmaTech Co., Ltd. ("Vcare PharmaTech"), under which Everest Medicines obtained the exclusive rights to develop, register and commercialize Sumecigrel (formerly known as Vicagrel), a P2Y12 receptor antagonist, in multiple countries and regions across Asia-Pacific, including Southeast Asia, South Korea, Australia, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan region, China...
Han Kun again recognized in MIP's IP STARS rankings
Managing Intellectual Property (MIP), a world-renowned IP publication, has recently announced its 2026 global IP STARS rankings. Han Kun was again recognized in the China domestic firm categories of "IP transactions (Tier 1)", "Patent disputes", "Trademark disputes", "Patent prosecution", and "Copyright", owing to the firm's competitive IP division and exceptional service capabilities. This is the sixth consecutive year for Han Kun to appear in the rankings, which reflects MIP's affirmation of the firm's comprehensive strength and influence.Besides these firm-level accolades, Han Kun partners Lili Wu and Yan Wang were recognized as "IP Stars" again...